Back

Improving kidney disease and preventing HF in T2D-associated CKD with finerenone

12 May 2024 (12:42 - 12:55)
Organised by: Logo
Congress Presentation Part of: Protecting the heart and kidneys: the role of finerenone Treatment HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Peter Rossing

Steno Diabetes Center, Copenhagen, Herlev (Denmark)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor S. Solomon (Boston, US)
Slides
Presentation thumbnail
The heart and kidney interlink and its role in driving CKD and heart failure
Professor B. Bozkurt (Houston, US)
Slides
Presentation thumbnail
Investigating the role of finerenone in the care of patients with heart failure
Professor J. Butler (Dallas, US) Professor S. Solomon (Boston, US)
Slides
Presentation thumbnail
Q&A and close
Professor S. Solomon (Boston, US)
Slides

Access the full session

Session thumbnail
Protecting the heart and kidneys: the role of finerenone
Video

The Event

Event poster

Heart Failure 2024

12 May 2024 12:42 CET
You may be interested in
thumbnail
Congress Presentation
Effect of finerenone on morbidity and mortality in chronic kidney disease and type 2 diabetes: FINE-HEART analysis of 3 randomized clinical trials
19 May 2025
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025
thumbnail
Congress Presentation
Welcome and introductions​
30 August 2025
thumbnail
Congress Presentation
Updated recommendations for the prevention of heart failure
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources